HopeStage
Study directory

Depression studies

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

Back to overview
More filters: keywords, city, remote
7264studies shown
Showing 1-12 of 7,264
Drug study icon
RecruitingNCT06132178

Psilocybin rTMS for Treatment Resistant Depression

What is this study about?

This study evaluates the safety and effectiveness of Psilocybin for people with depression.

In Austin
DepressionMedication studyAges 22–65
Countries
United States
Sponsor
University of Texas at Austin
Device study icon
RecruitingNCT07603804

Accelerated iTBS for Major Depression

What is this study about?

A short description of this study's objective has not yet been verified by HopeStage.

In Istanbul
DepressionDevice studyAges 18–65
Countries
Türkiye
Sponsor
Istanbul University - Cerrahpasa
Drug study icon
RecruitingNCT07562191

Inhaled DMT for depression

What is this study about?

Researchers are evaluating the effects and safety of different inhaled DMT doses in adults with depression.

In Natal
Depression, SuicidalityInhaled medicationAges 18+
Countries
Brazil
Sponsor
Universidade Federal do Rio Grande do Norte
Drug study icon
Not Yet RecruitingNCT07555743

Daridorexant for depression

What is this study about?

A short description of this study's objective has not yet been verified by HopeStage.

This study isn't recruiting yet.

In Barcelona
DepressionMedication studyAges 18–99
Countries
Spain
Sponsor
Institut d'Investigació Biomèdica de Bellvitge
Drug study icon
RecruitingNCT07523048

Dextromethorphan-bupropion for depression

What is this study about?

Researchers are studying how dextromethorphan-bupropion affects brain responses related to reward processing in adults with depression.

In Toronto
DepressionMedication + MRIAges 18–65
Countries
Canada
Sponsor
Roger McIntyre
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.